Table 3-4.
Diseases | Remaining Lifetime Risk at Age 40 y
|
Remaining Lifetime Risk at Age 70 y
|
||
---|---|---|---|---|
Men | Women | Men | Women | |
Any CVD* | 2 in 3 | 1 in 2 | 1 in 2 | 1 in 2 |
CHD6 | 1 in 2 | 1 in 3 | 1 in 3 | 1 in 4 |
AF23 | 1 in 4 | 1 in 4 | 1 in 4 | 1 in 4 |
CHF24 | 1 in 5 | 1 in 5 | 1 in 5 | 1 in 5 |
Stroke25 | 1 in 6† | 1 in 5† | 1 in 6 | 1 in 5 |
Dementia25 | … | … | 1 in 7 | 1 in 5 |
Hip fracture38 | 1 in 20 | 1 in 6 | … | … |
Breast cancer39,42 | 1 in 1000 | 1 in 8 | … | 1 in 14 |
Prostate cancer39 | 1 in 6 | … | … | … |
Lung cancer39 | 1 in 12 | 1 in 17 | … | … |
Colon cancer39 | 1 in 16 | 1 in 17 | … | … |
Diabetes43 | 1 in 3 | 1 in 3 | 1 in 9 | 1 in 7 |
Hypertension44 | 9 in 10† | 9 in 10† | 9 in 10‡ | 9 in 10‡ |
Obesity45 | 1 in 3 | 1 in 3 | … | … |
CVD indicates cardiovascular disease; ellipses (…), not estimated; CHD, coronary heart disease; AF, atrial fibrillation; and CHF, congestive heart failure.
Personal communication from Donald Lloyd-Jones, based on Framingham Heart Study data.
Age 55 y.
Age 65 y.